查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572217

全球噬菌體市場：按類型、產品、形式、交付方式、應用、最終用戶 - 預測 2025-2030

Bacteriophage Market by Type (Lysogenic, Lytic), Product (Phage Diagnostic Products, Phage Research Tools, Phage Therapy Products), Form, Delivery Mode, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年全球噬菌體市場價值為4774萬美元，預計2024年將達到5015萬美元，預計2030年將達到6835萬美元，複合年成長率為5.26%。

噬菌體是一種感染並裂解特定細菌的病毒，因其作為對抗抗生素抗藥性感染疾病和控制微生物組的精密工具的潛力而受到關注。隨著對替代抗菌治療的需求不斷成長，在解決抗生素抗藥性危機的需求和對個人化醫療日益成長的興趣的推動下，全球噬菌體市場預計將擴大。應用範圍廣泛，包括醫療保健、農業和食品安全，其中噬菌體用於增強作物保護和防止食品腐敗。最終使用範圍主要是醫院、診所、研究機構和農業部門。關鍵的成長要素包括對噬菌體療法認知的提高、客製化噬菌體解決方案的基因工程的進步以及各國為簡化市場准入而提供的監管支持。然而，市場開拓受到高昂的開發成本、複雜的核准和法律規範以及醫療保健專業人員認知度低的限制。此外，雖然噬菌體特異性是一個優勢，但它也可能是一個挑戰，因為它需要針對每種細菌菌株的專門解決方案。最新的潛在商機包括開發合成噬菌體和聯合治療、與農業部門建立基於噬菌體的生物農藥的夥伴關係以及擴大噬菌體庫以涵蓋更廣泛的傳染性病原體。建議包括投資有針對性的行銷宣傳活動以提高醫療保健相關人員的接受度、促進與生物技術公司的合作夥伴關係以簡化生產以及實現應用組合多樣化，其中包括尋求與多個地區的合作夥伴關係。儘管面臨挑戰，合成生物學的進步和輸送系統的創新等領域仍提供了巨大的差異化機會。噬菌體-宿主相互作用的研究和噬菌體穩定性的最佳化可能會進一步增加商業性可行性。了解當地市場變化和監管環境對於利用當地商機至關重要，而遞送機制和噬菌體配方的持續創新是在這個快速成長的市場中發展業務的最佳途徑。

主要市場統計
基準年[2023] 4774萬美元
預測年份 [2024] 5015萬美元
預測年份 [2030] 6835萬美元
複合年成長率（%） 5.26%

市場動態：揭示快速發展的全球噬菌體市場的關鍵市場洞察

全球噬菌體市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 抗生素抗藥性細菌感染疾病的流行推動了全球噬菌體療法的需求
    • 加大研發投入，推動噬菌體在全球醫療保健領域的應用
    • 越來越多的人認知到並接受噬菌體世界是抗生素的可行替代品
    • 擴大噬菌體在提高食品安全和農業生產力的全球應用
  • 市場限制因素
    • 醫療保健專業人員和患者對噬菌體療法的認知和接受度較低
    • 與現有抗生素治療的激烈競爭限制了噬菌體的全球治療採用
  • 市場機會
    • 透過與製藥公司合作加速全球噬菌體藥物開發平臺
    • 將噬菌體世界應用於獸醫學，以改善動物健康和食品生產
    • 噬菌體整體療法以及與常規抗生素合併使用的協同效應
  • 市場挑戰
    • 噬菌體全局治療缺乏標準化方案阻礙了臨床採用和一致性。
    • 噬菌體具有高度特異性，必須針對不同的細菌菌株單獨開發。

波特五力：開拓全球噬菌體市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對全球噬菌體市場的外部影響

外部宏觀環境因素在塑造全球噬菌體市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解全球噬菌體市場競爭狀況

全球噬菌體市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

全球FPNV定位矩陣噬菌體市場供應商績效評估

FPNV定位矩陣是評估全球噬菌體市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製全球噬菌體市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對全球噬菌體市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 抗生素抗藥性病菌感染的增加正在推動噬菌體全球治療的需求
      • 加大噬菌體醫療保健全球應用研發投入
      • 大眾對噬菌體作為抗生素可行替代品的認知和接受度正在提高
      • 擴大噬菌體在提高食品安全和農業生產力的全球應用
    • 抑制因素
      • 醫療保健專業人員和患者對噬菌體全球療法的認知和接受度有限
      • 與現有抗生素治療的激烈競爭限制了噬菌體全球療法的採用
    • 機會
      • 旨在與製藥公司合作加速藥物開發平臺
      • 在獸醫領域實施噬菌體的全球應用，以改善動物健康和食品生產
      • 利用噬菌體的整體療法與傳統抗生素結合以產生協同效應
    • 任務
      • 噬菌體全局治療缺乏標準化通訊協定阻礙了臨床採用和一致性
      • 噬菌體具有高度特異性，需要針對不同菌株進行單獨開發
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章全球噬菌體市場：依類型

  • 溶原性
  • 溶解度

第7章噬菌體的全球市場：依產品

  • 噬菌體診斷產品
  • 噬菌體研究工具
  • 噬菌體治療產品

第8章全球噬菌體市場：依形式

  • 液體
  • 固體的

第 9 章按遞送方式分類的噬菌體全球市場

  • 可注射的
  • 口服
  • 話題

第10章全球噬菌體市場：依應用分類

  • 農業
  • 診斷
  • 治療性的
    • 人性化治療
    • 獸醫治療

第11章全球噬菌體市場：依最終用戶分類

  • 醫院和診所
  • 製藥公司
  • 調查機構

第12章：美洲噬菌體的世界市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區噬菌體全球市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章：歐洲、中東和非洲的噬菌體世界市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C03A9

The Bacteriophage Market was valued at USD 47.74 million in 2023, expected to reach USD 50.15 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 68.35 million by 2030.

Bacteriophages, viruses that infect and lyse specific bacteria, have garnered attention for their potential in combating antibiotic-resistant infections and as precision tools in microbiome modulation. With an escalating need for alternative antibacterial treatments, the bacteriophage market is set to expand, propelled by the necessity to address antibiotic resistance crises and growing interest in personalized medicine. Applications extend across healthcare, agriculture, and food safety, where bacteriophages are used to enhance crop protection and prevent food spoilage. The end-use scope predominantly covers hospitals, clinics, research institutes, and agricultural sectors. Key growth factors include increasing awareness of phage therapy, advancements in genetic engineering which allow for tailored phage solutions, and regulatory support in several countries easing market entry. However, the market faces limitations such as high costs of development, complex regulatory frameworks for approval, and limited awareness among healthcare professionals. Additionally, phages' specificity, while an advantage, can also pose a challenge as it necessitates tailored solutions for each bacterial strain. The latest potential opportunities lie in the development of synthetic phages and combination therapies, creating partnerships with agriculture sectors for phage-based biopesticides, and expanding phage libraries to cover a broader range of infectious pathogens. Recommendations include investing in targeted marketing campaigns to increase acceptance among medical professionals, fostering collaborations with biotechnology firms to streamline production, and pursuing multi-regional partnerships to diversify application portfolios. Despite challenges, areas like synthetic biology advancements and delivery system innovations present ripe opportunities for differentiation. Research into phage-host interactions and optimizing phage stability could further enhance commercial viability. Understanding regional market variations and regulatory landscapes will be crucial for capitalizing on local opportunities, while continuous innovation in delivery mechanisms and phage formulations offer the best avenues for business growth in this burgeoning market.

KEY MARKET STATISTICS
Base Year [2023] USD 47.74 million
Estimated Year [2024] USD 50.15 million
Forecast Year [2030] USD 68.35 million
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bacteriophage Market

The Bacteriophage Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
    • Rising investments in research and development for bacteriophage applications in healthcare
    • Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
    • Expansion of bacteriophage application in food safety and agricultural productivity enhancement
  • Market Restraints
    • Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
    • High competition from established antibiotic treatments limiting bacteriophage therapy adoption
  • Market Opportunities
    • Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
    • Implementing bacteriophage use in veterinary medicine to improve animal health and food production
    • Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
  • Market Challenges
    • Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
    • High specificity of bacteriophages requiring individualized development for different bacterial strains

Porter's Five Forces: A Strategic Tool for Navigating the Bacteriophage Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bacteriophage Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bacteriophage Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bacteriophage Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bacteriophage Market

A detailed market share analysis in the Bacteriophage Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bacteriophage Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bacteriophage Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bacteriophage Market

A strategic analysis of the Bacteriophage Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bacteriophage Market, highlighting leading vendors and their innovative profiles. These include Adaptive Phage Therapeutics, AmpliPhi Biosciences Corporation, Armata Pharmaceuticals Inc., ContraFect Corporation, CYTOO S.A., Eligo Bioscience, EnBiotix Inc., Fixed-Phage Limited, Intralytix Inc., iNtRON Biotechnology, Locus Biosciences Inc., Micreos BV, Optipharm Co. Ltd., Phage International Inc., Phagelux Inc., Phagomed Biopharma GmbH, Pherecydes Pharma, Phico Therapeutics Ltd., Sexton Biotechnologies, and TechnoPhage SA.

Market Segmentation & Coverage

This research report categorizes the Bacteriophage Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Lysogenic and Lytic.
  • Based on Product, market is studied across Phage Diagnostic Products, Phage Research Tools, and Phage Therapy Products.
  • Based on Form, market is studied across Liquid and Solid.
  • Based on Delivery Mode, market is studied across Injectable, Oral, and Topical.
  • Based on Application, market is studied across Agricultural, Diagnostic, and Therapeutic. The Therapeutic is further studied across Human Therapeutic and Veterinary Therapeutic.
  • Based on End-User, market is studied across Hospitals and Clinics, Pharmaceutical Companies, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
      • 5.1.1.2. Rising investments in research and development for bacteriophage applications in healthcare
      • 5.1.1.3. Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
      • 5.1.1.4. Expansion of bacteriophage application in food safety and agricultural productivity enhancement
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
      • 5.1.2.2. High competition from established antibiotic treatments limiting bacteriophage therapy adoption
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
      • 5.1.3.2. Implementing bacteriophage use in veterinary medicine to improve animal health and food production
      • 5.1.3.3. Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
      • 5.1.4.2. High specificity of bacteriophages requiring individualized development for different bacterial strains
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bacteriophage Market, by Type

  • 6.1. Introduction
  • 6.2. Lysogenic
  • 6.3. Lytic

7. Bacteriophage Market, by Product

  • 7.1. Introduction
  • 7.2. Phage Diagnostic Products
  • 7.3. Phage Research Tools
  • 7.4. Phage Therapy Products

8. Bacteriophage Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Solid

9. Bacteriophage Market, by Delivery Mode

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Bacteriophage Market, by Application

  • 10.1. Introduction
  • 10.2. Agricultural
  • 10.3. Diagnostic
  • 10.4. Therapeutic
    • 10.4.1. Human Therapeutic
    • 10.4.2. Veterinary Therapeutic

11. Bacteriophage Market, by End-User

  • 11.1. Introduction
  • 11.2. Hospitals and Clinics
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutions

12. Americas Bacteriophage Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Bacteriophage Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Bacteriophage Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adaptive Phage Therapeutics
  • 2. AmpliPhi Biosciences Corporation
  • 3. Armata Pharmaceuticals Inc.
  • 4. ContraFect Corporation
  • 5. CYTOO S.A.
  • 6. Eligo Bioscience
  • 7. EnBiotix Inc.
  • 8. Fixed-Phage Limited
  • 9. Intralytix Inc.
  • 10. iNtRON Biotechnology
  • 11. Locus Biosciences Inc.
  • 12. Micreos BV
  • 13. Optipharm Co. Ltd.
  • 14. Phage International Inc.
  • 15. Phagelux Inc.
  • 16. Phagomed Biopharma GmbH
  • 17. Pherecydes Pharma
  • 18. Phico Therapeutics Ltd.
  • 19. Sexton Biotechnologies
  • 20. TechnoPhage SA

LIST OF FIGURES

  • FIGURE 1. BACTERIOPHAGE MARKET RESEARCH PROCESS
  • FIGURE 2. BACTERIOPHAGE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BACTERIOPHAGE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BACTERIOPHAGE MARKET DYNAMICS
  • TABLE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE RESEARCH TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HUMAN THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIOPHAGE MARKET SIZE, BY VETERINARY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIOPHAGE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 324. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023